- Sell-side engagement
- Buyer-side engagement
- Identifying prospective strategic or financial buyers on a global basis
TRUSTED. QUALITY. DOMAIN EXPERTISE.
Boutique M&A and Strategic Advisory firm with a focus on the healthcare and life sciences sectors.
Who We Are
Healthcare and Life Sciences professionals with deep domain expertise developed over +25 years in M&A, corporate development, and strategic advisory with unparalleled networks in the industry and finance sectors. We commit to providing high-quality services to our clients so that they can make the best decisions possible for their business.
About Us
We are industry veterans keenly focused on utilizing deep sector insights and extensive deal-making experience to provide impactful advisory services.
Our Goal
We are committed to providing candid, objective advice that serves the best interests of our clients, not ours.
OUR SERVICES
Our boutique-style service and responsiveness are designed to help clients achieve their goals by identifying opportunities and streamlining the transactional process through deep industry specialization.
- In-licensing
- Out-licensing and divestitures
- Evaluating strategic options and positioning your business in a compelling way for future growth or exit
- Outsourced Chief Business Officer / Corporate Development
CLIENTS WE SERVE
Companies
- Pharmaceutical
- Biotechnology
- Medical Device
- Medical Technology
- Aesthetic/ Cosmetic
- Consumer/ OTC
- Genomics
- Healthcare/ IT
- Life science tools
- Diagnostics
- CDMO
- CRO (clinical and preclinical)
- Research Services
Therapeutic and Diagnostic Area Expertise
- Aesthetics
- Cardiovascular
- Dermatology
- Gastroenterology
- Inflammatory/ Auto-immune
- Immunology
- Movement Disorders
- Neurology
- Oncology
- Ophthalmology
- Orthopedics
- Rare Diseases
- Women’s Health
RECENT POSTS
Healthcare 2021: M&A Perspectives Across the Country
February 22, 2021
USA Pharma Report 2020
January 29, 2021
Axial M&A Outlook 2021 – Lower Middle Market
January 27, 2021
Contact us to find out how we can help your business.
LEADERSHIP TEAM
David H. Crean
Managing Partner
David H. Crean, Ph.D is a Managing Partner at Cardiff Advisory. Previously, Dr. Crean served as Managing Director for Objective Capital Partners, a middle market investment banking firm located in southern California, where he led the firm’s Mergers and acquisitions (M&A), partnering, valuations and capital financing transactions with life science and healthcare companies. Dr. Crean has in excess of 25 years of transactional experience. Dr. Crean holds FINRA Series 79 and Series 63 licenses and is a FINRA Registered Investment Banking Representative through BA Securities, LLC.
E: david.crean@cardiffadvisory.com | P: 858-245-4905
In parallel to his investment banking and strategic advisory leadership for Cardiff Advisory, Dr. Crean currently serves as a Senior Advisor to Objective Capital's Investment Banking services, and is in leading roles on the Boards of Directors for Histogen, Inc. (Nasdaq: HSTO) as Board Chairman and Chair of Audit, and the California Life Sciences Association (CLSA) as Chairman of Development and a member of the Executive Committee. He is a limited partner with a leading life sciences venture fund, Mesa Verde Venture Partners, and a member of BIOCOM and Corporate Directors Forum. Dr. Crean is also a contributing author for Forbes.com, through his work with Forbes Los Angeles Business Council, and PharmaBoardRoom.com. For his outstanding advisory work, Dr. Crean was recognized by San Diego Business Journal for SD500 Most Influential Business Leaders in 2019 and 2020, M&A Advisors for the 2019 Investment Banker of the Year, San Diego Business Journal’s 2018 Healthcare Hero, 2017 Thought Leader of the Year and 2017 Advisor of the Year Awards. Dr. Crean is also active in the non-profit sector where he serves in leading Board of Director roles for the Association for Corporate Growth (ACG) San Diego as President, and as Chairman of the Board for the Alzheimer’s Association of San Diego/ Imperial Counties and Student Success Programs of the Charter School of San Diego.
Dr. Crean holds a Masters of Business Administration (MBA) Degree with a finance concentration from Pepperdine University Graziadio School of Management. Additionally, he holds a Doctorate of Philosophy (Ph.D.) Degree in Biophysics and a Masters of Science (MS) Degree in Oncology from the State University of New York at Buffalo. Dr. Crean also earned a Bachelor of Science (BS) Degree in Biology/ Pre-Med from Canisius College.
Alexander B. Johns
Senior Advisor
Alexander Johns is Chairmain of Arete Strategies, LLC, an advisory firm providing market research, analytics, and strategic input on business development, product development, marketing, and commercialization for biopharmaceutical companies. Mr. Johns has in excess of 30 years of experience in the life sciences and healthcare industries working with C-Suite executives and Boards of Directors in defining, refining, and executing strategies for growth and exit. Mr. Johns earned his BS and MBA from the University of Chicago, Booth School of Business.
E: johns@aretestrat.com | P: 619-985-4616
Awards
COMMUNITY COMMITMENT & GIVING BACK
Our firm is committed to investing its time, talent, and treasure in local and national charities that drive impact in the communities that they serve. A portion of the firm’s profits supports the missions of various leading organizations including:
